- Home
- SNYR vs DXR Comparison
SNYR vs DXR Comparison
Compare SNYR & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNYR
- DXR
- Stock Information
- Founded
- SNYR 2010
- DXR 1970
- Country
- SNYR United States
- DXR United States
- Employees
- SNYR N/A
- DXR N/A
- Industry
- SNYR
- DXR Medical/Dental Instruments
- Sector
- SNYR
- DXR Health Care
- Exchange
- SNYR NYSE
- DXR Nasdaq
- Market Cap
- SNYR 43.3M
- DXR 37.6M
- IPO Year
- SNYR N/A
- DXR N/A
- Fundamental
- Price
- SNYR $4.07
- DXR $8.50
- Analyst Decision
- SNYR
- DXR Strong Buy
- Analyst Count
- SNYR 0
- DXR 1
- Target Price
- SNYR N/A
- DXR $24.75
- AVG Volume (30 Days)
- SNYR 17.2K
- DXR 6.8K
- Earning Date
- SNYR 01-01-0001
- DXR 01-01-0001
- Dividend Yield
- SNYR N/A
- DXR N/A
- EPS Growth
- SNYR N/A
- DXR N/A
- EPS
- SNYR 0.61
- DXR 0.35
- Revenue
- SNYR $37,781,229.00
- DXR $154,205.00
- Revenue This Year
- SNYR N/A
- DXR N/A
- Revenue Next Year
- SNYR N/A
- DXR N/A
- P/E Ratio
- SNYR $6.67
- DXR $24.39
- Revenue Growth
- SNYR N/A
- DXR N/A
- 52 Week Low
- SNYR $4.03
- DXR $7.19
- 52 Week High
- SNYR $10.00
- DXR $10.02
- Technical
- Relative Strength Index (RSI)
- SNYR N/A
- DXR 54.80
- Support Level
- SNYR N/A
- DXR $8.01
- Resistance Level
- SNYR N/A
- DXR $8.51
- Average True Range (ATR)
- SNYR 0.00
- DXR 0.31
- MACD
- SNYR 0.00
- DXR 0.10
- Stochastic Oscillator
- SNYR 0.00
- DXR 99.07
About SNYR SYNERGY CHC CORP
Synergy CHC Corp is a consumer health care company. It is in the business of marketing and distributing consumer branded products through various distribution channels primarily in the health and wellness industry. The company's products include FOCUSfactor, Flat Tummy Tea, Hand MD, and Neuragen amongst others. Synergy generates the majority of its revenue from the sale of Flat Tummy Tea, which is exclusively sold online at www.flattummyco.com. Flat Tummy Tea is a uniquely formulated two-step herbal detox tea that works to naturally help speed metabolism, boost energy and reduce bloating.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.